Renal Cell Carcinoma News and Research

Latest Renal Cell Carcinoma News and Research

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

New nanoplatform technology may reverse drug-resistance in renal cell carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

Ipsen receives approval from Health Canada for CABOMETYX tablets for treating renal cell carcinoma

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Novel approach reveals metabolic vulnerabilities in kidney cancer

Novel approach reveals metabolic vulnerabilities in kidney cancer

New approach to assess kidney tumors could prevent patients from undergoing unnecessary surgery

New approach to assess kidney tumors could prevent patients from undergoing unnecessary surgery

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Biomarker predicts kidney cancer risk years before diagnosis

Biomarker predicts kidney cancer risk years before diagnosis

Blood biomarker could help predict kidney cancer up to five years prior to diagnosis

Blood biomarker could help predict kidney cancer up to five years prior to diagnosis

ZHX2 protein could offer a new treatment strategy for kidney cancer

ZHX2 protein could offer a new treatment strategy for kidney cancer

Cancer patients receiving anti-PD-1 therapies may experience delayed skin reactions

Cancer patients receiving anti-PD-1 therapies may experience delayed skin reactions

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Analysis of lymph node dissection shows no overall survival benefit in renal carcinoma patients

Analysis of lymph node dissection shows no overall survival benefit in renal carcinoma patients

Depleted metabolic enzymes contribute to tumor growth in renal cancer

Depleted metabolic enzymes contribute to tumor growth in renal cancer

Non-aspirin NSAID use linked to shorter survival in patients with metastatic renal cell carcinoma

Non-aspirin NSAID use linked to shorter survival in patients with metastatic renal cell carcinoma

Study finds link between industry payments and prescription practices for two cancer types

Study finds link between industry payments and prescription practices for two cancer types

Immunotherapy combination increases overall survival in people with kidney cancer, study shows

Immunotherapy combination increases overall survival in people with kidney cancer, study shows

Oncolytic virus alerts the immune system to attack tumors

Oncolytic virus alerts the immune system to attack tumors

Researchers identify mechanism that regulates signaling events leading to cancer metastasis

Researchers identify mechanism that regulates signaling events leading to cancer metastasis